Ironwood Pharmaceuticals | Le Coût Des Ventes



Cost Of Sales Changement Date
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Almirall EUR 16.73M 73.47M 2024-06
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amarin USD 26.02M 1.3M 2024-09
Ardelyx USD 18.26M 2.54M 2024-12
Astellas Pharma JPY 98.52B 15.83B 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Charles River Laboratories USD 682.87M 40.87M 2024-12
Exact Sciences USD 284.13M 88.06M 2024-12
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
Incyte USD 82.38M 2.49M 2024-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
MacroGenics USD 5.49M 3.62M 2024-12
Moderna USD 546M 246M 2024-12
Myriad Genetics USD 59.7M 3.8M 2024-12
Pacira USD 39.89M 1.02M 2024-12
PTC Therapeutics USD 16.28M 5.44M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Takeda JPY 416.87B 22.56B 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12



Ironwood Pharmaceuticals Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.